Reversal of albuminuria by combined AM6545 and perindopril therapy in experimental diabetic nephropathy.

Barutta, F; Bellini, S; Mastrocola, R; Gambino, R; Piscitelli, F; di Marzo, V; Corbetta, B; Vemuri, V K; Makriyannis, A; Annaratone, L; Bruno, G; Gruden, G

Barutta, F; Bellini, S; Mastrocola, R; Gambino, R; Piscitelli, F; di Marzo, V; Corbetta, B; Vemuri, V K; Makriyannis, A; Annaratone, L; Bruno, G; Gruden, G.

Affiliation

Barutta F; Department of Medical Sciences, University of Turin, Turin, Italy.
Bellini S; Department of Medical Sciences, University of Turin, Turin, Italy.
Mastrocola R; Department of Clinical and Biological Sciences, University of Turin, Turin, Italy.
Gambino R; Department of Medical Sciences, University of Turin, Turin, Italy.
Piscitelli F; Endocannabinoid Research Group, Institute of Biomolecular Chemistry - CNR, Pozzuoli, Italy.
di Marzo V; Endocannabinoid Research Group, Institute of Biomolecular Chemistry - CNR, Pozzuoli, Italy.
Corbetta B; Department of Medical Sciences, University of Turin, Turin, Italy.
Vemuri VK; Center for Drug Discovery, Northeastern University, Boston, MA, USA.
Makriyannis A; Center for Drug Discovery, Northeastern University, Boston, MA, USA.
Annaratone L; Department of Medical Sciences, University of Turin, Turin, Italy.
Bruno G; Department of Medical Sciences, University of Turin, Turin, Italy.
Gruden G; Department of Medical Sciences, University of Turin, Turin, Italy.

Br J Pharmacol ; 175(23): 4371-4385, 2018 12.

Article de En | MEDLINE | ID: mdl-30184259

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Pyrazoles / Morpholines / Périndopril / Diabète expérimental / Néphropathies diabétiques / Albuminurie Limites: Animals Langue: En Journal: Br J Pharmacol Année: 2018 Type de document: Article Pays d'affiliation: Italie

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google